PMGC Holdings Inc.
- Last sale
- Nov 12, 2026 · +7.79%
- Market cap
- $1.94M
- 1.17M shares
- Filings
- 275
Q3 2026−65.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2025
—Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+35.6% FY25 yoy
- $1.94M
- —
- 3.3×
- 0.2×
- -328.59%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $590,084 | reported | |
| FY 2023 | 2023-12-31 | $1,712,595 | reported | |
| FY 2022 | 2022-12-31 | $766,277 | reported |
Pharmaceutical preparations
PMGC Holdings Inc. is the 224th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MCRBSeres Therapeutics, Inc.$789.0K—721.9%$14.4MLEXXLexaria Bioscience Corp.$705.9K52.0%1,686.0%$102.4MPMHSPolomar Health Services, Inc.$648.2K1,002.0%1,650.8%$3.7MBTAIQBioXcel Therapeutics, Inc.$642.0K71.7%10,887.4%$313.1K
ELABPMGC Holdings Inc. (this company)$590.1K—1,313.0%$1.9M
YARWYarrow Bioscience, Inc.$570.0K13.8%4,646.1%$296.8MSLNSilence Therapeutics plc$559.0K98.7%15,851.9%$3.7BQUCYQuantum Cyber N.V.$537.1K39.9%3,018.3%$49.2MMREOMereo BioPharma Group plc$500.0K—8,375.6%$243.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
PMGC Holdings Inc. · CIK 1840563 · Engraved from SEC EDGAR